Amazon-Studie 23

Hightlights of the Amazon Study 23

Market Overview: Amazon's sales, forecasts & market shares on the German market
Amazon Pharmacy: This is what a possible launch in Germany could look like, and these are the lessons Amazon is learning from the U.S.
Exclusive pharmaceutical company survey: Survey on the sales and advertising behavior of manufacturers on Amazon
Amazon Advertising: Efficient predictive advertising on Amazon through AI
KPI benchmark vs. e-pharmacies: analyses of availability, prices & keywords of pharmaceutical products on Amazon
Opportunities & Best Practice: Amazon's algorithm and successes through product page optimization

The following download is a document in German language.

Amazon has arrived in the pharmacy market. Pharmaceutical industry players have never been more aware of Amazon's relevance as an advertising and sales channel. Amazon is still at the beginning of its journey, but has arrived in the pharmaceutical market. The mail-order giant has now become an indispensable channel not only in the lifestyle segment, but also in the healthcare industry - even without Amazon Pharmacy launching in Germany.

In the current pharmaceutical company survey, 93% of respondents said they were actively involved with Amazon (+8% year-on-year). Overall, a full 62% of respondents consider Amazon to be an important sales channel for pharmaceuticals. In 2022, nonRx pharma products generated sales of approximately €239 million on Amazon, with growth of 27%. By 2025, nonRx sales will triple at a CAGR of 46%, according to study estimates.

This is according to the latest Amazon Study 23 by the two Kaske Group companies Smile BI and Dr. Vital.